Hemispherx BioPharma (NYSEAMERICAN:HEB) Executives Voluntarily Forgo 2024 Cash Bonuses
On December 19, 2024, Hemispherx BioPharma (NYSEAMERICAN:HEB) disclosed in an 8-K filing that executives Thomas K. Equels and Peter W. Rodino III have voluntarily decided to waive their entitlement to cash bonuses for the year 2024. This decision was communicated to the Compensation Committee of the Company’s Board of Directors as a means to assist […]
More Stories
QUINT Self Reported Market Capitalization Achieves $1.17 Million (QUINT)
QUINT (QUINT) traded up 1% against the U.S. dollar during the 1-day period ending at 10:00 AM E.T. on December...
Terra Price Reaches $0.44 on Top Exchanges (LUNA)
Terra (LUNA) traded down 0.4% against the dollar during the 1 day period ending at 10:00 AM E.T. on December...
Axie Infinity (AXS) Reaches Self Reported Market Cap of $1.02 Billion
Axie Infinity (AXS) traded 1.7% higher against the US dollar during the one day period ending at 10:00 AM ET...
TerraClassicUSD (USTC) Price Hits $0.0204
TerraClassicUSD (USTC) traded down 0.8% against the US dollar during the 24 hour period ending at 10:00 AM Eastern on...
GENinCode (LON:GENI) Trading Up 2.9% – Should You Buy?
GENinCode Plc (LON:GENI – Get Free Report)’s stock price traded up 2.9% during trading on Thursday . The company traded...
Toray Industries, Inc. (OTCMKTS:TRYIY) Short Interest Update
Toray Industries, Inc. (OTCMKTS:TRYIY – Get Free Report) was the target of a large decline in short interest in the...